Barclays Starts PTC Therapeutics (PTCT) at Overweight, 'We think PKU could be >$2B at peak'
Tweet Send to a Friend
(Updated - January 28, 2026 6:20 AM EST)
Barclays analyst Eliana Merle initiates coverage on PTC Therapeutics (NASDAQ: PTCT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Eliana Merle initiates coverage on PTC Therapeutics (NASDAQ: PTCT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
